1,422
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The optimal gestational age to deliver patients with chronic hypertension on antihypertensive therapy

ORCID Icon, ORCID Icon, , , , , & show all
Article: 2210727 | Received 12 Jan 2023, Accepted 01 May 2023, Published online: 07 May 2023

References

  • Bateman BT, Bansil P, Hernandez-Diaz S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134.e1-8–134.e8.
  • Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National institute of child health and human development network of Maternal-Fetal medicine units. N Engl J Med. 1998;339(10):667–671.
  • Zetterström K, Lindeberg SN, Haglund B, et al. The association of maternal chronic hypertension with perinatal death in male and female offspring: a record linkage study of 866,188 women. BJOG. 2008;115(11):1436–1442.
  • Vigil-De Gracia P, Lasso M, Montufar-Rueda C. Perinatal outcome in women with severe chronic hypertension during the second half of pregnancy. Int J Gynaecol Obstet. 2004;85(2):139–144.
  • Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med. 2007;52(11):1046–1051.
  • Chronic Hypertension in Pregnancy. ACOG practice bulletin no. 203. American college of obstetrics and gynecologists. Obstet Gynecol. 2019;133(1):e26–e50.
  • Tita AT, Landon MB, Spong CY, et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med. 2009;360(2):111–120.
  • Clark SL, Miller DD, Belfort MA, et al. Neonatal and maternal outcomes associated with elective term delivery. Am J Obstet Gynecol. 2009;200(2):156.e1-4–156.e4.
  • Harper LM, Biggio JR, Anderson S, et al. Gestational age of delivery in pregnancies complicated by chronic hypertension. Obstet Gynecol. 2016;127(6):1101–1109.
  • Ram M, Berger H, Geary M, et al. Diabetes, obesity and hypertension in pregnancy research network (DOH-NET) and the Southern Ontario obstetrical network (SOON) investigators. Timing of delivery in women with chronic hypertension. Obstet Gynecol. 2018;132(3):669–677.
  • Hutcheon JA, Lisonkova S, Magee LA, et al. Optimal timing of delivery in pregnancies with pre-existing hypertension. BJOG. 2011;118(1):49–54.
  • Chappell LC, Enye S, Seed P, et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51(4):1002–1009.
  • Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.
  • Lecarpentier E, Tsatsaris V, Goffinet F, et al. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PLoS One. 2013;8(5):e62140.
  • Garovic VD, Dechend R, Easterling T, et al. American heart association council on hypertension; council on the kidney in cardiovascular disease, kidney in heart disease science committee; council on arteriosclerosis, thrombosis and vascular biology; council on lifestyle and cardiometabolic health; council on peripheral vascular disease; and stroke council. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American heart association. Hypertension. 2022;79(2):e21–e41.
  • Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10(10):CD002252.
  • Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013;2013(7):CD001449.
  • Allen SE, Tita A, Anderson S, et al. Is use of multiple antihypertensive agents to achieve blood pressure control associated with adverse pregnancy outcomes? J Perinatol. 2017;37(4):340–344.
  • Tita AT, Szychowski JM, Boggess K, et al. Chronic hypertension and pregnancy (CHAP) trial consortium. N Engl J Med. 2022;386(19):1781–1792. May 12
  • Society for Maternal-Fetal Medicine Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy: The CHAP Trial. 2020. https://www.smfm.org/publications/439-smfm-statement-antihypertensive-therapy-for-mild-chronic-hypertension-in-pregnancy-the-chap-trial